Beacon Pharmaceuticals
Introduction
Beacon Pharmaceuticals Ltd., established in 2001 and headquartered in Dhaka, Bangladesh, is a pioneering pharmaceutical company renowned for its focus on innovation and excellence. It is the first company in Bangladesh to build a dedicated oncology manufacturing facility compliant with global standards.
Beacon specializes in producing high-quality medicines, including lifesaving drugs for cancer, hepatitis, and chronic illnesses, making advanced healthcare accessible to patients worldwide.
Therapeutic Specializations
Beacon Pharmaceuticals caters to a diverse range of therapeutic areas:
- Oncology (Cancer Treatment)
- Hepatology
- Cardiology
- Neurology and CNS Disorders
- Infectious Diseases
- Immunology
- Diabetes Management
- Respiratory Care
Global Reach
Beacon Pharmaceuticals exports its products to over 130 countries, demonstrating its robust global presence. Key markets include:
- Asia: India, Nepal, Sri Lanka, and the Philippines.
- Africa: Kenya, South Africa, Nigeria, and Ghana.
- Middle East: UAE, Saudi Arabia, and Jordan.
- Europe: Several countries, focusing on high-quality generics and biosimilars.
- Latin America: Expanding its footprint in markets like Brazil and Mexico.
- North America: Actively exploring opportunities to enter regulated markets.
Research and Development (R&D)
Beacon invests heavily in R&D, particularly in oncology, virology, and biologics. The company focuses on developing complex generics, targeted therapies, and novel drug delivery systems. Beacon’s research-driven approach enables it to bring cutting-edge treatments to market, addressing unmet medical needs.
Manufacturing Excellence
Beacon boasts state-of-the-art manufacturing facilities certified by global regulatory authorities, including the US FDA, EMA, and WHO. Its facilities specialize in producing high-quality tablets, capsules, injectables, and biologics. Beacon’s dedicated oncology manufacturing unit adheres to strict global standards, ensuring the production of contamination-free medicines.
Social Responsibility
Beacon is deeply committed to social welfare. Through its corporate social responsibility (CSR) initiatives, the company provides free or subsidized medicines to underprivileged patients. It also engages in programs to raise awareness about diseases like cancer and hepatitis.
Key Products
- Oncology Drugs: Erlotinib, Sorafenib, and Lenalidomide.
- Hepatitis Treatments: Sofosbuvir, Velpatasvir, and Daclatasvir.
- COVID-19 Medications: Remdesivir and Favipiravir.
- Diabetes Management: Metformin and Glimepiride combinations.
- Respiratory Care: Asthma inhalers and COPD treatments.
